Diagnosis of patients with suspected chronic hepatitis C infection
Journal Title: Annals of Hepatology - Year 2010, Vol 9, Issue 0
Abstract
The current optimal approach to detecting hepatitis C virus (HCV) infection involves screening people for risk factors and only testing selected individuals at risk. Blood transfusion from infectious donors, unsafe therapeutic injection practices, and illegal intravenous drug use have been the predominant modes of transmissiomn of HCV infection. Virological markers that are currently used for the clinical management of patients with hepatitis C include serologic assays (ELISA or immunoblot assays), which detect specific antibodies (IgG) to HCV, and virological assays, which detect serum HCV RNA, by highly sensitive qualitative and quantitative techniques. The applicability of these tests is for the diagnoses and monitoring of the treatment but they have no role in the assessment of disease severity or prognosis. Patients diagnosed with HCV infection must be educated in order to avoid the spread of the disease to other people.
Authors and Affiliations
Adrián Gadano, Omar Galdame, Sebastián Marciano
Keywords
Related Articles
- EP ID EP77960
- DOI -
- Views 142
- Downloads 0
Improvement of hepatic fibrosis by leukotriene inhibition in cholestatic rats
Chronic liver disease is characterized by inflammation and fibrosis. Angiogenesis which leading to new vasculature may have prognostic value in disease progression. This study examined the implication of 5-lipoxygenase p...
Complete remission of visceral and cutaneous Kaposi´s sarcoma after liver-kidney transplantati
Good outcomes of liver transplantation for hepatitis C at a low volume centre
Background and aims. Concerns exist about outcomes of liver transplantation (LT) from low volume centres, especially for hepatitis C (HCV) patients. The aim of the study was to assess patient outcomes as well as their pr...
Impact of the severity of end-stage liver disease in cardiac structure and function
[b]Background[/b]. The impact of end-stage liver disease (ESLD) in cardiac remodeling of patients with cirrhosis is unknown. Our aim was to correlate the severity of ESLD with morphologic and functional heart changes. [b...
LncRNA-Regulated Autophagy and its Potential Role in Drug-Induced Liver Injury
Background and aim. Autophagy and its regulated pathways participate in many important cellular physiology and pathological processes involving protein aggregates, damaged mitochondria, excessive peroxisomes, ribosomes,...